JPMorgan Chase & Co. Cuts Itron (NASDAQ:ITRI) Price Target to $113.00

Itron (NASDAQ:ITRI) had its price target decreased by JPMorgan Chase & Co. from $133.00 to $113.00 in a report issued on Thursday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the scientific and technical instruments company’s stock.

Several other equities research analysts have also recently issued reports on ITRI. Oppenheimer raised their target price on shares of Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday. Wall Street Zen cut shares of Itron from a “buy” rating to a “hold” rating in a research report on Wednesday, January 14th. Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Johnson Rice raised shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 target price on the stock in a research report on Monday, January 5th. Finally, Weiss Ratings cut shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Eight research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Itron currently has a consensus rating of “Moderate Buy” and an average price target of $133.10.

Itron Price Performance

Itron stock opened at $98.43 on Thursday. Itron has a 12-month low of $83.51 and a 12-month high of $142.00. The stock has a market capitalization of $4.36 billion, a P/E ratio of 15.12, a P/E/G ratio of 0.84 and a beta of 1.50. The firm’s 50-day moving average is $93.73 and its two-hundred day moving average is $101.55. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56.

Itron (NASDAQ:ITRI) last released its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The company had revenue of $571.66 million for the quarter, compared to analysts’ expectations of $561.31 million. During the same period last year, the company earned $1.35 EPS. The firm’s revenue for the quarter was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Equities analysts predict that Itron will post 5.33 earnings per share for the current year.

Insider Activity

In other Itron news, SVP John F. Marcolini sold 6,948 shares of Itron stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $691,603.92. Following the transaction, the senior vice president directly owned 26,912 shares of the company’s stock, valued at $2,678,820.48. The trade was a 20.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Justin K. Patrick sold 4,930 shares of Itron stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total transaction of $490,732.20. Following the transaction, the senior vice president directly owned 34,344 shares in the company, valued at approximately $3,418,601.76. This trade represents a 12.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 51,180 shares of company stock valued at $5,085,475 over the last quarter. 1.77% of the stock is owned by insiders.

Institutional Trading of Itron

Hedge funds have recently made changes to their positions in the company. DLD Asset Management LP raised its stake in shares of Itron by 49.9% during the third quarter. DLD Asset Management LP now owns 63,400 shares of the scientific and technical instruments company’s stock valued at $7,897,000 after purchasing an additional 21,100 shares during the period. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Itron during the third quarter valued at approximately $1,300,000. Robeco Schweiz AG raised its stake in shares of Itron by 31.2% during the third quarter. Robeco Schweiz AG now owns 372,176 shares of the scientific and technical instruments company’s stock valued at $46,358,000 after purchasing an additional 88,504 shares during the period. J. Safra Sarasin Holding AG purchased a new stake in shares of Itron during the third quarter valued at approximately $4,673,000. Finally, Envestnet Asset Management Inc. raised its stake in shares of Itron by 34.0% during the third quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company’s stock valued at $18,474,000 after purchasing an additional 37,634 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.